Although there are relatively few studies on S100A11 in metabolic diseases, these published works indicate that S100A11 may play an important role in the development and progression of other metabolic diseases, not only T2D and NAFLD. Here, S100A11 is linked to metabolic dysfunction-associated steatotic liver disease.